AbstractThe human ABCG2 (ABCP/MXR/BCRP) protein is a recently recognized ABC half-transporter, which forms homodimers in the plasma membrane and actively extrudes a wide variety of chemically unrelated compounds from the cells. This protein protects our cells and tissues against various xenobiotics, with a crucial role in the intestine, liver, placenta, and the blood–brain barrier. Moreover, ABCG2 seems to have a key function in stem cell protection/regulation, and also in hypoxic defense mechanisms. Widely occurring single nucleotide polymorphisms in ABCG2 may affect absorption and distribution, altering the effectiveness and toxicity of drugs in large populations. At the clinics, overexpression of ABCG2 in tumor cells confers cancer multi...
To study the function and expression of nine naturally occurring single-nucleotide polymorphisms (G4...
ABCG2 is one of at least three human ATP binding cassette (ABC) transporters which can facilitate th...
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of structur...
AbstractThe human ABCG2 (ABCP/MXR/BCRP) protein is a recently recognized ABC half-transporter, which...
AbstractExpression of multidrug resistance ABC transporters has been suggested as a functional marke...
Kohji Noguchi, Kazuhiro Katayama, Yoshikazu Sugimoto Division of Chemotherapy, Faculty of Pharmacy, ...
ABC (ATP binding cassette) transporters are a diverse superfamily of membrane proteins, which couple...
The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and prote...
AbstractThe human ABCG2 protein is an ATP binding cassette half-transporter, which protects our cell...
ABCG2 ou BCRP est une protéine membranaire de la famille des transporteurs ABC. Elle utilise l’énerg...
Multidrug resistance is a major obstacle to successful cancer treatment. One mechanism by which cell...
Abstract Single nucleotide polymorphism (SNP) anal-yses of the ABCG2 gene have revealed three nonsyn...
ABCG2 is best known as a multidrug transporter capable of conferring resistance to cancer cells. How...
Emerging evidence from research or clinical studies reported that ABCG2 (ATP-binding cassette sub-fa...
The Breast Cancer Resistance Protein (BCRP/ABCG2) is one member of ABC transporters proteins super f...
To study the function and expression of nine naturally occurring single-nucleotide polymorphisms (G4...
ABCG2 is one of at least three human ATP binding cassette (ABC) transporters which can facilitate th...
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of structur...
AbstractThe human ABCG2 (ABCP/MXR/BCRP) protein is a recently recognized ABC half-transporter, which...
AbstractExpression of multidrug resistance ABC transporters has been suggested as a functional marke...
Kohji Noguchi, Kazuhiro Katayama, Yoshikazu Sugimoto Division of Chemotherapy, Faculty of Pharmacy, ...
ABC (ATP binding cassette) transporters are a diverse superfamily of membrane proteins, which couple...
The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and prote...
AbstractThe human ABCG2 protein is an ATP binding cassette half-transporter, which protects our cell...
ABCG2 ou BCRP est une protéine membranaire de la famille des transporteurs ABC. Elle utilise l’énerg...
Multidrug resistance is a major obstacle to successful cancer treatment. One mechanism by which cell...
Abstract Single nucleotide polymorphism (SNP) anal-yses of the ABCG2 gene have revealed three nonsyn...
ABCG2 is best known as a multidrug transporter capable of conferring resistance to cancer cells. How...
Emerging evidence from research or clinical studies reported that ABCG2 (ATP-binding cassette sub-fa...
The Breast Cancer Resistance Protein (BCRP/ABCG2) is one member of ABC transporters proteins super f...
To study the function and expression of nine naturally occurring single-nucleotide polymorphisms (G4...
ABCG2 is one of at least three human ATP binding cassette (ABC) transporters which can facilitate th...
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of structur...